Cum funcționează noul vaccin personalizat împotriva cancerului

Merck and Moderna's personalized cancer vaccine shows promise in preventing melanoma recurrence, potentially transforming cancer treatment. The vaccine trains the immune system to target specific tumor mutations, differing from traditional therapies. Initial studies indicate significant efficacy, with further research underway for various cancers. Experts express optimism about the future of personalized cancer vaccines.